Comparative Effectiveness and Safety of Monodrug Therapies f... : Medicine Comparative
Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated …

Abstract Context Alpha-blockers (ABs) and 5-alpha reductase inhibitors have an established
role in treating male lower urinary tract symptoms (LUTS) attributed to benign prostatic …

Introduction Lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH)
are common in elder men and a number of drugs alone or combined are clinically used for …

We conducted a systematic review to evaluate the efficacy and adverse effects of newer
drugs used to treat lower urinary tract symptoms (LUTS). The drugs were either Food and …

Introduction Benign prostatic hyperplasia (BPH) represents the histological entity of prostate
cell proliferation, which inflicts a gradually increasing obstruction of the bladder outlet and is …

Background: The first Italian national guidelines were developed by the Italian Association of
Urologists and published in 2007. Since then, a number of new drugs or classes of drugs …

Benign prostatic hyperplasia (BPH) is the most common benign disease of the prostate
gland and is caused by benign hyperplasia of the smooth muscle cells and stromal cells in …

Introduction: Benign prostatic hyperplasia (BPH) is a common condition affecting over 50%
of men as they reach their 5th decade of life. This leads to a number of sequelae such as …

Benign prostatic hyperplasia (BPH) is the nonmalignant enlargement of the prostate gland
caused by increases in number of both epithelial and stromal cells. Clinically, BPH leads to …

Purpose: Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing
proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The …